FPC
CADX

Falcon Point Capital’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Falcon Point Capital’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-113,808
Closed -$1.03M – 134
2013
Q4 		$1.03M Hold
113,808
– – 0.98% 30
2013
Q3 		$717K Buy
113,808
+21,591
+23% +$136K 0.76% 51
2013
Q2 		$629K Buy
+92,217
New +$629K 0.69% 56